PH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Parker-Hannifin is a good buy right now for a beginner focused on long-term investing with $50,000-$100,000 to deploy. The stock has a constructive technical setup, strong analyst support, favorable congressional buying, and no recent negative news flow. While insider selling and the lack of fresh news are mild negatives, the overall setup remains positive, and the current price is still below the highest analyst targets. Given the user’s preference to act now rather than wait for a perfect entry, I would rate it a buy.
PH is in an uptrend structurally, with bullish moving averages (SMA_5 > SMA_20 > SMA_200). The MACD histogram is positive at 2.873, though it is contracting, which suggests momentum is still positive but not accelerating. RSI_6 at 55.192 is neutral-to-slightly bullish, not overbought. Price at 953.73 is below the pivot of 966.381 but above S1 at 938.269, keeping the stock in a favorable near-term range. The technical picture supports a long-term entry, though not a strong breakout signal.
["Truist raised its price target to $1,269 and kept a Buy rating, citing strong sector demand and secular tailwinds in power, data center, aerospace/defense, and infrastructure.", "Deutsche Bank issued a Catalyst call: Buy, expecting the stock\u2019s underperformance to reverse as investors favor short-cycle industrial exposure.", "Citi said the post-earnings selloff was overdone and highlighted robust defense and power generation orders.", "Congressional trading data shows 1 purchase and 0 sales in the last 90 days, indicating positive institutional-like political sentiment.", "No negative news in the recent week, which leaves the stock\u2019s bullish analyst and demand narrative intact."]
["Insiders are selling, and selling activity increased 141.58% over the last month.", "Hedge funds are neutral with no significant trading trend over the last quarter.", "The MACD histogram is positive but contracting, so near-term momentum is not strengthening.", "No fresh news catalysts in the last week, which limits immediate event-driven upside."]
No latest quarter financial snapshot was provided due to data error, so a direct quarter-over-quarter assessment is unavailable. However, analyst commentary suggests the business is seeing strong order momentum and improved demand trends, with expectations for solid earnings performance and potentially improving EPS guidance. This supports a positive growth narrative even without the hard quarterly figures.
Analyst sentiment is clearly positive overall. Recent actions include Truist raising its target to $1,269 with a Buy rating, Deutsche Bank initiating a Catalyst call Buy, and multiple firms maintaining Overweight/Outperform/Buy views. A few firms trimmed targets in May, but they still kept constructive ratings. The trend in price targets has been mixed but generally supportive, with the newest and most bullish update pointing meaningfully above the current price. Wall Street’s pros view: strong demand, secular growth tailwinds, and order momentum. Cons view: some prior target cuts, valuation sensitivity, and the stock’s recent underperformance versus high targets.
